Users Coming Off Slimming Injections Put On Weight at a Quadrupled Rate Than Those on Conventional Diets

A recent study reveals that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who end conventional diet and exercise programs.

Published data in a prominent medical journal points out that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"Individuals using such treatments must be informed of the risk of rapid rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.

That rate of regain suggests a return to original weight in about 18 months.

Comparing Therapies

The analysis, which looked at 37 of trials involving thousands of patients, compared the outcomes of these new drugs with older methods.

Scientists emphasize that individuals who shed pounds through dieting usually have a more gradual weight regain—approximately 100 grams monthly—after stopping.

The Reason for the Rapid Regain

Nutrition scientists suggest the mechanism of the jabs is key to understanding the amplified rebound.

The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to appetite is no longer kept in check, making excessive eating much more probable."

A Lifelong Condition?

Medical guidelines suggest the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

Professionals contend that, given the significant potential of weight regain, the treatment might need to be ongoing.

This opinion is reinforced by drug manufacturers, who say that the findings "emphasize the long-term character of obesity," comparing it to managing diseases like diabetes.

User Testimonies

People who have stopped the medication explain a powerful resurgence of hunger.

"It was like a trigger flipping and you become ravenous," described an individual.

This difficulty is worsened if individuals have not adopted sustainable lifestyle or habit changes during treatment.

Widespread Use

Survey data indicate that millions of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

• Adoption is more common among females compared to men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private prescriptions rather than public health services.

Ultimately, experts caution that while the jabs are potent tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on ongoing lifestyle management.